Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1331-1340 of 1755 for cancer

Edit search filters
  1. A Study To Evaluate Effectiveness And Quality Of Life Outcomes Of Daratumumab In Relapsed/Refractory Multiple Myeloma Patients

    Rochester, MN

  2. Development of Novel Mutation Detection Methods for Lung Cancer

    Rochester, MN

  3. Deep Learning-based Automated Segmentation of Organs at Risk in Treat Head and Neck Radiotherapy

    Rochester, MN

  4. Detecting Significant Prostate Cancer Based on Molecular Alterations Associated With Cancer in Non-neoplastic Prostate Tissue

    Rochester, MN

  5. Histology of Functional Density in Premenopausal Breast

    Rochester, MN

  6. A Study to Determine the Effects of Activity by Ambulation in Hospital Premises versus Strict Protective Isolation on Quality of Life in Severely Neutropenic Cancer Patients during Hospitalization

    Jacksonville, FL

  7. Evaluation Of 18F-TFB PET/CT Scan In Patients With Differentiated Thyroid Cancer

    Rochester, MN

  8. Alpha-1 AD Carriers and Lung Cancer Risk

    Rochester, MN

  9. Clinical And Epidemiological Studies In Pediatric Malignancies

    Rochester, MN

  10. Defining The Immunologic Profile Of Sentinel Lymph Nodes And Identifying The Mechanisms Responsible For Immunosuppression

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer